Industry News
Pharmaceutical Industry News
Could Lowering Inflammation Treat Depression?
Psychiatrists think inflammation may be at the root of some people’s illness. How to treat it is an open question.
Most of those two weeks is not…
Most of those two weeks is not science. It is finding and assembling the data, which is also where most of the AI sold to pharma quietly stalls.
Pfizer’s CFO Dave Denton will…
Pfizer's CFO Dave Denton will officially depart in August, leaving SVP of finance Cecile Guegan to take up his post in the interim.
With interest in automated cell…
With interest in automated cell therapy production beginning to build from about 2016 onward, some 23 companies working in the field have now raised a collective $1.1 billion across 34 rounds through April 24, data
The Thriving Black Market for a Powerful Weight Loss Drug
People are buying what they believe to be retatrutide from WhatsApp groups, Chinese labs and websites selling it “for research purposes.”
Name recognition and “familiarity”…
Name recognition and "familiarity" with Novo Nordisk's oral Wegovy has contributed to its rapid uptake in its battle with Lilly's oral GLP-1 Foundayo, according to Spherix analyst Jim Hickey, who conducts monthly surveys with doctors
Four years after Spero…
Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treatment for complicated urinary tract infections, the company and its partner GSK have pushed Utebzi across the finish line.
With good-but-not-great updated…
With good-but-not-great updated data on its approved oncology combo of avutometinib plus defactinib in first-line metastatic pancreatic cancer, Verastem Oncology will now channel its primary R&D efforts toward other pipeline darlings.
Less than a month after an…
Less than a month after an approval for Daiichi Sankyo and AstraZeneca’s Datroway for front-line TNBC patients who are not candidates for PD-1/L1 inhibitors, the FDA has handed Gilead’s Trodelvy a rivaling approval that allows
Eighteen months after Novo Nordisk…
Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it is set to kick off the manufacturing of ingredients for next-generation diabetes and obesity drugs at
GSK has launched the first…
GSK has launched the first direct-to-consumer TV spot for Exdensur, stepping up promotion of an asthma drug that the company is tipping to generate blockbuster sales.
Two different hacking rings…
Two different hacking rings acquired sensitive information from Novo and allegedly attempted to extort the company out of millions of dollars.
Amid multiple efforts to rein in…
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own hands, albeit through a framework that may be difficult to pull off
Pharma companies have been part of…
Pharma companies have been part of the global economy and health systems for centuries. Now, as drugmakers play a more visible role in mainstream conversations about health and culture, Big Pharma is rethinking how it
With pharma and life sciences deal…
With pharma and life sciences deal values surpassing $65 billion in the first quarter, marking the strongest quarter in the industry since 2020, analysts from PwC have declared that the “biopharma ecosystem is back to
The program looks to support…
The program looks to support "faster, more coordinated approaches to emerging regulatory challenges and decisions," the United Kingdom's MHRA said.
As it prepares to launch up to…
As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. The company has hired Ester Banque to become its CCO and has elevated
Stealth BioTherapeutics is looking…
Stealth BioTherapeutics is looking to put its tumultuous path behind it with a new name.
Recipharm has sketched out a…
Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for customers.
DeepIntent has launched an agentic…
DeepIntent has launched an agentic AI tool to help healthcare marketers more efficiently extract insights from databases using natural language.